SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-230240
Filing Date
2024-10-01
Accepted
2024-10-01 16:37:53
Documents
13
Period of Report
2024-10-01
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K d823075d8k.htm   iXBRL 8-K 23530
  Complete submission text file 0001193125-24-230240.txt   144473

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20241001.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20241001_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20241001_pre.xml EX-101.PRE 11262
15 EXTRACTED XBRL INSTANCE DOCUMENT d823075d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 241343888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)